Escitalopram Tablets USP 20 mg, 100-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Baltimore, MD, 21202, Manufactured by: Lupin Limited, Goa 403 722, India, NDC 68180-136-01

FDA recall notice · announced September 28, 2016 · Lupin Limited

Class III FDA/FSIS Class III: use is not likely to cause adverse health consequences.

The product

Escitalopram Tablets USP 20 mg, 100-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Baltimore, MD, 21202, Manufactured by: Lupin Limited, Goa 403 722, India, NDC 68180-136-01

Reason for recall

Labeling: Incorrect or Missing Lot and/or Expiration Date

Notes

Distribution: Nationwide
Lot/code information: Lot # G510086; Exp. 11/17
Quantity: 3,192 bottles (319,200 tablets)
Status: Terminated
Products in this recall event:
- Escitalopram Tablets USP 20 mg, 100-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Baltimore, MD, 21202, Manufactured by: Lupin Limited, Goa 403 722, India, NDC 68180-136-01 (D-1516-201)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.